0001654954-21-011064.txt : 20211013
0001654954-21-011064.hdr.sgml : 20211013
20211013170057
ACCESSION NUMBER: 0001654954-21-011064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211011
FILED AS OF DATE: 20211013
DATE AS OF CHANGE: 20211013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brannan Michael A.
CENTRAL INDEX KEY: 0001807248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22893
FILM NUMBER: 211321775
MAIL ADDRESS:
STREET 1: C/O AEHR TEST SYSTEMS
STREET 2: 400 KATO TERRACE
CITY: FREMONT
STATE: CA
ZIP: 94539
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AEHR TEST SYSTEMS
CENTRAL INDEX KEY: 0001040470
STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825]
IRS NUMBER: 942424084
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 400 KATO TERRACE
CITY: FREMONT
STATE: CA
ZIP: 94539
BUSINESS PHONE: 5106239400
MAIL ADDRESS:
STREET 1: 400 KATO TERRACE
CITY: FREMONT
STATE: CA
ZIP: 94539
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2021-10-11
0001040470
AEHR TEST SYSTEMS
AEHR
0001807248
Brannan Michael A.
C/O AEHR TEST SYSTEMS
400 KATO TERRACE
FREMONT
CA
94539
true
V.P. of Operations
Common Stock
2021-10-11
4
M
false
14000
1.2200
A
28826
D
Common Stock
2021-10-11
4
S
false
17000
18.8000
D
11826
D
Common Stock
2021-10-12
4
M
false
14125
1.2200
A
25951
D
Incentive Stock Option (right to buy)
1.2200
2021-10-11
4
M
false
14000
0.0000
D
2020-04-16
2027-03-16
Common Stock
14000
61000
D
Incentive Stock Option (right to buy)
1.2200
2021-10-12
4
M
false
14125
0.0000
D
2020-04-16
2027-03-16
Common Stock
14125
46875
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $19.67, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
The amount reported includes shares subject to unvested restricted stock units.
One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.
/s/ Michael A. Brannan
2021-10-13